BR9912889A - Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound - Google Patents
Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compoundInfo
- Publication number
- BR9912889A BR9912889A BR9912889-6A BR9912889A BR9912889A BR 9912889 A BR9912889 A BR 9912889A BR 9912889 A BR9912889 A BR 9912889A BR 9912889 A BR9912889 A BR 9912889A
- Authority
- BR
- Brazil
- Prior art keywords
- carboxylic acid
- preparation
- pharmaceutical
- compounds
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"DERIVADO DE áCIDO CARBOXìLICO, PREPARAçãO FARMACêUTICA, USO DOS DERIVADOS DO áCIDO CARBOXìLICO, USO DOS COMPOSTOS, PREPARAçãO DE COMBINAçãO FARMACêUTICA, USO DE UM FRAGMENTO ESTRUTURAL, E, COMPOSTO" A invenção diz respeito a novos derivados de ácido carboxílico da fórmula I onde os substituintes têm os significados explicados na descrição, à sua preparação e ao seu uso como antagonistas do receptor de endotelina."CARBOXYLIC ACID DERIVATIVE, PHARMACEUTICAL PREPARATION, USE OF CARBOXYLIC ACID DERIVATIVES, USE OF COMPOUNDS, PREPARATION OF PHARMACEUTICAL COMBINATION, USE OF A STRUCTURAL FRAGMENT, AND, COMPOUND" the invention relates to new acid derivatives substituents have the meanings explained in the description, their preparation and their use as endothelin receptor antagonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19836044A DE19836044A1 (en) | 1998-08-10 | 1998-08-10 | New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer |
PCT/EP1999/005728 WO2000009489A1 (en) | 1998-08-10 | 1999-08-07 | New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9912889A true BR9912889A (en) | 2001-05-08 |
Family
ID=7876981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9912889-6A BR9912889A (en) | 1998-08-10 | 1999-08-07 | Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1104410A1 (en) |
JP (1) | JP2002522531A (en) |
KR (1) | KR20010072378A (en) |
CN (1) | CN1323298A (en) |
AR (1) | AR020147A1 (en) |
AU (1) | AU5374199A (en) |
BG (1) | BG105236A (en) |
BR (1) | BR9912889A (en) |
CA (1) | CA2340167A1 (en) |
CO (1) | CO5261504A1 (en) |
DE (1) | DE19836044A1 (en) |
HK (1) | HK1042086A1 (en) |
HR (1) | HRP20010164A2 (en) |
HU (1) | HUP0104007A3 (en) |
ID (1) | ID27965A (en) |
IL (1) | IL140915A0 (en) |
NO (1) | NO20010622D0 (en) |
PL (1) | PL345998A1 (en) |
SK (1) | SK832001A3 (en) |
TR (1) | TR200100427T2 (en) |
WO (1) | WO2000009489A1 (en) |
ZA (1) | ZA200101975B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19924892A1 (en) * | 1999-06-01 | 2000-12-07 | Basf Ag | New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19636046A1 (en) * | 1996-09-05 | 1998-03-12 | Basf Ag | New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists |
-
1998
- 1998-08-10 DE DE19836044A patent/DE19836044A1/en not_active Withdrawn
-
1999
- 1999-08-07 HU HU0104007A patent/HUP0104007A3/en unknown
- 1999-08-07 SK SK83-2001A patent/SK832001A3/en unknown
- 1999-08-07 IL IL14091599A patent/IL140915A0/en unknown
- 1999-08-07 AU AU53741/99A patent/AU5374199A/en not_active Abandoned
- 1999-08-07 PL PL99345998A patent/PL345998A1/en not_active Application Discontinuation
- 1999-08-07 TR TR2001/00427T patent/TR200100427T2/en unknown
- 1999-08-07 KR KR1020017001731A patent/KR20010072378A/en not_active Application Discontinuation
- 1999-08-07 ID IDW20010326A patent/ID27965A/en unknown
- 1999-08-07 EP EP99939457A patent/EP1104410A1/en not_active Withdrawn
- 1999-08-07 WO PCT/EP1999/005728 patent/WO2000009489A1/en not_active Application Discontinuation
- 1999-08-07 CN CN99811981A patent/CN1323298A/en active Pending
- 1999-08-07 BR BR9912889-6A patent/BR9912889A/en not_active Application Discontinuation
- 1999-08-07 CA CA002340167A patent/CA2340167A1/en not_active Abandoned
- 1999-08-07 JP JP2000564942A patent/JP2002522531A/en active Pending
- 1999-08-10 CO CO99050715A patent/CO5261504A1/en not_active Application Discontinuation
- 1999-08-10 AR ARP990103985A patent/AR020147A1/en not_active Application Discontinuation
-
2001
- 2001-02-06 NO NO20010622A patent/NO20010622D0/en not_active Application Discontinuation
- 2001-02-09 BG BG105236A patent/BG105236A/en unknown
- 2001-03-08 HR HR20010164A patent/HRP20010164A2/en not_active Application Discontinuation
- 2001-03-09 ZA ZA200101975A patent/ZA200101975B/en unknown
-
2002
- 2002-05-15 HK HK02103679.0A patent/HK1042086A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19836044A1 (en) | 2000-02-17 |
PL345998A1 (en) | 2002-01-14 |
NO20010622L (en) | 2001-02-06 |
WO2000009489A1 (en) | 2000-02-24 |
HUP0104007A3 (en) | 2002-12-28 |
NO20010622D0 (en) | 2001-02-06 |
IL140915A0 (en) | 2002-02-10 |
TR200100427T2 (en) | 2001-07-23 |
EP1104410A1 (en) | 2001-06-06 |
AU5374199A (en) | 2000-03-06 |
CA2340167A1 (en) | 2000-02-24 |
SK832001A3 (en) | 2001-11-06 |
HUP0104007A2 (en) | 2002-05-29 |
AR020147A1 (en) | 2002-04-10 |
CN1323298A (en) | 2001-11-21 |
BG105236A (en) | 2001-12-29 |
KR20010072378A (en) | 2001-07-31 |
JP2002522531A (en) | 2002-07-23 |
HRP20010164A2 (en) | 2002-04-30 |
ID27965A (en) | 2001-05-03 |
ZA200101975B (en) | 2002-03-11 |
HK1042086A1 (en) | 2002-08-02 |
CO5261504A1 (en) | 2003-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9606957A (en) | Solid preparation process for its production using the same and solid pharmaceutical form | |
SE8804629D0 (en) | NEW THERAPEUTICALLY ACTIVE COMPOUNDS | |
FR2789079B3 (en) | PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
BR0017030B8 (en) | thiazolylamide derivatives, process for their preparation, pharmaceutical composition comprising them and their use | |
BR9911871B1 (en) | phenoxyacetic acid derivatives and pharmaceutical compositions containing them. | |
BR0008840B1 (en) | camptothecin derivatives, processes for their preparation, pharmaceutical composition comprising them and use thereof. | |
PT894084E (en) | CINAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRINE ANTAGONISTS | |
ATE284861T1 (en) | N-ARALKYLAMINOTETRALINES AS NEUROPEPTIDE Y-Y5 RECEPTOR LIGANDS | |
FI963566A0 (en) | New piperazine derivatives, methods for their preparation and compositions containing them | |
PT1254134E (en) | 1,3-DIHYDRO-2H-INDOL-2-ONA DERIVATIVES AND THEIR USE AS LIGANDS FOR ARGININE-VASOPRESSIN V1B OR V1B AND V1A RECEPTORS | |
EE05054B1 (en) | Oral pharmaceutical composition of a 5-HT4 agonist or antagonist and its use in medicine | |
BR9706386A (en) | Vitronectin receptor antagonists, their preparation and their use | |
IT9021662A0 (en) | PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING SODIUM HYLUROMICOSAL ACID AND DISINFECTANT SUBSTANCES | |
BR9814951A (en) | Carboxylic acid derivative, use of it, preparation of medication for oral, parenteral use, combination, use of compounds, structural fragment, use of it, endothelin receptor antagonist, and, compound | |
BR0211995A (en) | Combination preparations of aryl substituted propanolamine derivatives with other active substances and their application | |
IT8919193A0 (en) | IMIDAZOLONE DERIVATIVES WITH ANTIHYPERTENSIVE ACTIVITY, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
PT101444A (en) | SYNERGIZING ASSOCIATION WITH ANTAGONIST EFFECT OF RECEPTORS NK1 AND NK2, USE OF ANTAGONIST ACTIVITY OF NK1 AND NK2 RECEPTORS IN THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE REFERENCE ASSOCIATION | |
CR6398A (en) | 5HT1 ANTAGONISTS FOR ANTIDEPRESSIVE THERAPY | |
DE59610175D1 (en) | HYDANTO DERIVATIVES AS INTERMEDIATE PRODUCTS FOR PHARMACEUTICAL ACTIVE SUBSTANCES | |
CO4940448A1 (en) | GLASS MODIFICATION OF A MEDICINAL SUBSTANCE | |
BR0107922A (en) | Derivatives of dibenzo [b, f] azepine and their preparation | |
BR0009739A (en) | Compound, medicine, pharmaceutical preparation, and, uses of a structural element, a compound and a pharmaceutical preparation | |
IT1196150B (en) | DERIVATIVES OF 1- (BIS- (4-FLUOROFENIL) METHYL) -4- (3-FENYL-2-PROPENYL) -HESHYDRO-1H-1,4-DIAZEPIN ACTIVATED CALCIUM ANTAGONIST, ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT | |
BR9912889A (en) | Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound | |
BR9805437A (en) | Derivatives of heterocyclic benzocycloalkenes, process for manufacturing heterocyclic benzocycloalken derivatives and use of heterocyclic benzocycloalken derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |